1. Home
  2. VERU vs HFBL Comparison

VERU vs HFBL Comparison

Compare VERU & HFBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • HFBL
  • Stock Information
  • Founded
  • VERU 1971
  • HFBL 1924
  • Country
  • VERU United States
  • HFBL United States
  • Employees
  • VERU N/A
  • HFBL N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • HFBL Savings Institutions
  • Sector
  • VERU Health Care
  • HFBL Finance
  • Exchange
  • VERU Nasdaq
  • HFBL Nasdaq
  • Market Cap
  • VERU 40.6M
  • HFBL 41.6M
  • IPO Year
  • VERU 1990
  • HFBL N/A
  • Fundamental
  • Price
  • VERU $2.17
  • HFBL $15.31
  • Analyst Decision
  • VERU Strong Buy
  • HFBL
  • Analyst Count
  • VERU 2
  • HFBL 0
  • Target Price
  • VERU $25.00
  • HFBL N/A
  • AVG Volume (30 Days)
  • VERU 191.3K
  • HFBL 2.5K
  • Earning Date
  • VERU 12-15-2025
  • HFBL 10-23-2025
  • Dividend Yield
  • VERU N/A
  • HFBL 3.46%
  • EPS Growth
  • VERU N/A
  • HFBL 35.20
  • EPS
  • VERU N/A
  • HFBL 1.47
  • Revenue
  • VERU $16,886,419.00
  • HFBL $21,720,000.00
  • Revenue This Year
  • VERU N/A
  • HFBL N/A
  • Revenue Next Year
  • VERU N/A
  • HFBL N/A
  • P/E Ratio
  • VERU N/A
  • HFBL $10.46
  • Revenue Growth
  • VERU 337.24
  • HFBL 10.10
  • 52 Week Low
  • VERU $2.11
  • HFBL $12.27
  • 52 Week High
  • VERU $14.20
  • HFBL $16.95
  • Technical
  • Relative Strength Index (RSI)
  • VERU 25.21
  • HFBL 54.03
  • Support Level
  • VERU $2.11
  • HFBL $15.25
  • Resistance Level
  • VERU $2.57
  • HFBL $15.63
  • Average True Range (ATR)
  • VERU 0.20
  • HFBL 0.25
  • MACD
  • VERU -0.03
  • HFBL -0.07
  • Stochastic Oscillator
  • VERU 9.33
  • HFBL 41.29

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

About HFBL Home Federal Bancorp Inc. of Louisiana

Home Federal Bancorp Inc of louisiana operates as a bank holding company. It is a federally chartered stock savings bank, which provides financial services to individuals, corporate entities, and other organizations. Its core activities consist of attracting deposits from the general public and using those funds to originate loans to the residential, commercial and multi-family segments. The company also invests securities held-to-maturity and securities available for sale.

Share on Social Networks: